Skip to main content
. 2021 Jan 26;6(8):2372–2389. doi: 10.1016/j.bioactmat.2021.01.017

Fig. 4.

Fig. 4

(A) ROS measurement of ATDC5 cells after different samples treatment and subsequent IL-1β (10 ng/mL) stimulation for 72 h (scale bar: 45 μm). (B) Anti-apoptotic effects on ATDC5 cells of different samples after stimulation with IL-1β (10 ng/mL) for 72 h (scale bar: 45 μm). (C,D) The percent of DCFH-DA positive cells and TUNEL positive cells, respectively. * indicates p < 0.05; ***, ### indicate p < 0.001; ns indicates not significant. * indicates comparisons with the sham group and # indicates comparisons with the IL-1β treatment group.